NAGE - ChromaDex Stock Price

Chromadex Corp (NAGE) is developing high-demand biohacking and anti-aging solutions, expanding its distribution through online platforms. Management's strategy relies on patenting longevity research and securing strategic partnerships. The share price history on GURU.Markets recorded a value of 2.12. The business is moderately cyclical, as demand for dietary supplements depends on consumer wealth and exhibits quarterly seasonality.

NAGE - Niagen Price Rate Chart over the range 03/20/2025 - 11/13/2026

Metric breakdowns and analytics for ChromaDex (NAGE)

- stock value and consensus price forecast:

Price Chart Chromadex Corp|NAGE - Broker Consensus Forecast

- market capitalization statistics:

Market Capitalization ChromaDex Corp|NAGE - Enterprise Value

- book capitalization information:

Book Value per Share ChromaDex|NAGE - Book Value of Business|Market Capitalization to Book Value Ratio niagenbioscience.com|NAGE - Company Assets

- company liabilities and liquidity data:

- earnings and market ratios statistics:

NAGE - Net Income|Projected Future Earnings Chromadex Corp|NAGE - P/E Multiple|Future Price to Earnings ChromaDex Corporation|NAGE - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio ChromaDex Corp|NAGE - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) ChromaDex|NAGE - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months niagenbioscience.com|NAGE - Earnings per share growth this year|Net earnings per share growth forecast for next year Chromadex Corp

- revenue and sales details:

NAGE - Company Gross Revenue|Company Future Sales Volume ChromaDex|NAGE - Market Cap to Sales Volume|Price-to-Projected Revenue Ratio ChromaDex Corp

Analysis of all company metrics:Niagen

Chromadex Corp (NAGE) adherence to environmental standards in supplement production is reflected in the daily price action. The price captures the market valuation of management decisions and reacts promptly to strategic news. Technically, the indicator represents the ratio of total market capitalization to the number of shares outstanding. The increase in value raises investor expectations for future financial results. This asset belongs to the category of high-tech biochemical companies.

Who Chromadex Corp competes with